18F-fluorodeoxyglucose PET/CT in cancer imaging

被引：21

作者：

Kayani, Irfan ^{[1
]}

Groves, Ashley M. ^{[1
]}

机构：

[1] UCL Hosp, NHS Trust, Inst Nucl Med, London NW1 2BU, England

来源：

CLINICAL MEDICINE | 2006年 / 6卷 / 03期

关键词：

18F-fluorodeoxyglucose; oncology imaging; positron emission tomography (PET)/computed tomography (CT);

D O I：

10.7861/clinmedicine.6-3-240

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Non-small cell lung cancer: 18F-fluorodeoxyglucose (FOG) positron emission tomography (PET) (or PET/computed tomography (CT)) should be performed following staging CT scan for all patients with potentially operable cancer Colorectal cancer: PET/CT is not currently indicated for the diagnosis of primary colorectal cancer (CRC) PET/CT should be used where available as the initial staging modality in patients with suspected recurrent CRC Lymphoma: PET/CT should be used in initial staging of all patients with Hodgkin's lymphoma and aggressive non-Hodgkin's lymphoma (NHL) but not low-grade NHL PET/CT FDG uptake is more accurate than CT in determining response to therapy and prognosis following therapy Early interim treatment PET scans appear to be accurate predictors of long-term outcome in Hodgkin's lymphoma and NHL.

引用

页码：240 / 244

页数：5

共 15 条

[1] Comparison between 2-deoxy-2-[18F]fluoro-D-Glucose positron emission tomography and positron emission tomography/computed tomography hardware fusion for staging of patients with lymphoma [J].

Allen-Auerbach, M ;

Quon, A ;

Weber, WA ;

Obrzut, S ;

Crawford, T ;

Silverman, DHS ;

Ratib, O ;

Phelps, ME ;

Czernin, J .

MOLECULAR IMAGING AND BIOLOGY, 2004, 6 (06) :411-416

[2]

Board of the Faculty of Clinical Radiology, 2005, PET CT UK STRAT DEV

[3] Detection of recurrence in patients with rectal cancer: PET/CT after abdominoperineal or anterior resection [J].

Even-Sapir, E ;

Parag, Y ;

Lerman, H ;

Gutman, M ;

Levine, C ;

Rabau, M ;

Figer, A ;

Metser, U .

RADIOLOGY, 2004, 232 (03) :815-822

[4] Five-year survival after resection of hepatic metastases from colorectal cancer in patients screened by positron emission tomography with F-18 fluorodeoxyglucose (FDG-PET) [J].

Fernandez, FG ;

Drebin, JA ;

Linehan, DC ;

Dehdashti, F ;

Siegel, BA ;

Strasberg, SM .

ANNALS OF SURGERY, 2004, 240 (03) :438-447

[5] FDG-PET/CT in re-staging of patients with lymphoma [J].

Freudenberg, LS ;

Antoch, G ;

Schütt, P ;

Beyer, T ;

Jentzen, W ;

Müller, SP ;

Görges, R ;

Nowrousian, MR ;

Bockisch, A ;

Debatin, JF .

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2004, 31 (03) :325-329

[6]

Gambhir SS, 2001, J NUCL MED, V42, p1S

[7]

Kim JH, 2005, J NUCL MED, V46, P587

[8] Staging of non-small-cell lung cancer with integrated positron-emission tomography and computed tomography [J].

Lardinois, D ;

Weder, W ;

Hany, TF ;

Kamel, EM ;

Korom, S ;

Seifert, B ;

von Schulthess, GK ;

Steinert, HC .

NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (25) :2500-2507

[9] Update on 18F-fluorodeoxyglucose/positron emission tomography and positron emission tomography/computed tomography imaging of squamous head and neck cancers [J].

Menda, Y ;

Graham, MM .

SEMINARS IN NUCLEAR MEDICINE, 2005, 35 (04) :214-219

[10]

*NAT I CLIN EXC, 2005, CLIN GUID, V24

← 1 2 →